CRLF1 and CLCF1 in Development, Health and Disease

L Crisponi, I Buers, F Rutsch - International journal of molecular sciences, 2022 - mdpi.com
Cytokines and their receptors have a vital function in regulating various processes such as
immune function, inflammation, haematopoiesis, cell growth and differentiation. The …

Aging-and senescence-associated changes of mesenchymal stromal cells in myelodysplastic syndromes

D Mattiucci, G Maurizi, P Leoni… - Cell …, 2018 - journals.sagepub.com
Hematopoietic stem and progenitor cells reside within the bone marrow (BM)
microenvironment. By a well-balanced interplay between self-renewal and differentiation …

Obesity determines the immunophenotypic profile and functional characteristics of human mesenchymal stem cells from adipose tissue

G Pachón-Peña, C Serena, M Ejarque… - Stem Cells …, 2016 - academic.oup.com
Adipose tissue is a major source of mesenchymal stem cells (MSCs), which possess a
variety of properties that make them ideal candidates for regenerative and …

Bone marrow MSCs in MDS: contribution towards dysfunctional hematopoiesis and potential targets for disease response to hypomethylating therapy

Z Poon, N Dighe, SS Venkatesan, AMS Cheung, X Fan… - Leukemia, 2019 - nature.com
The study of myelodysplastic syndromes (MDS) in murine models has now indicated the
possible involvement of the bone marrow microenvironment in the generation of dysplastic …

Cardiotrophin-like cytokine factor 1 (CLCF1) and neuropoietin (NP) signalling and their roles in development, adulthood, cancer and degenerative disorders

NA Sims - Cytokine & growth factor reviews, 2015 - Elsevier
Mutations in cardiotrophin-like cytokine factor (CLCF1) and the related cytokine to which it
binds, cytokine receptor-like factor 1 (CRLF1), are associated with Crisponi/cold induced …

Cytotoxic therapy–induced effects on both hematopoietic and marrow stromal cells promotes therapy-related myeloid neoplasms

A Stoddart, J Wang, AA Fernald, EM Davis… - Blood cancer …, 2020 - AACR
Therapy-related myeloid neoplasms (t-MN) following treatment with alkylating agents are
characterized by a del (5q), complex karyotypes, alterations of TP53, and a dismal …

Transcriptomics of human multipotent mesenchymal stromal cells: Retrospective analysis and future prospects

N Kasoju, H Wang, B Zhang, J George, S Gao… - Biotechnology …, 2017 - Elsevier
The plastic-adherent, fibroblast-like, clonogenic cells found in the human body now defined
as multipotent “Mesenchymal Stromal Cells”(MSCs) hold immense potential for cell-based …

Sequential gene expression analysis of myelodysplastic syndrome transformation identifies HOXB3 and HOXB7 as the novel targets for mesenchymal cells in disease

C Yin, Y Li, C Zhang, S Zang, Z Wang, X Yan, T Ma… - BMC cancer, 2024 - Springer
Background Myelodysplastic syndrome (MDS) is known to arise through the pathogenic
bone marrow mesenchymal stem cells (MSC) by interacting with hematopoietic stem cells …

Iron overload regulate the cytokine of mesenchymal stromal cells through ROS/HIF-1α pathway in Myelodysplastic syndromes

J Hu, F Meng, X Hu, L Huang, H Liu, Z Liu, L Li - Leukemia Research, 2020 - Elsevier
Iron overload is a significant feature of myelodysplastic syndromes (MDS) patients due to
ineffective hematopoiesis and transfusion dependence. Excess iron results in organ …

Engagement of Mesenchymal Stromal Cells in the Remodeling of the Bone Marrow Microenvironment in Hematological Cancers

S Giallongo, A Duminuco, I Dulcamare, T Zuppelli… - Biomolecules, 2023 - mdpi.com
Mesenchymal stromal cells (MSCs) are a subset of heterogeneous, non-hematopoietic
fibroblast-like cells which play important roles in tissue repair, inflammation, and immune …